(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 17.83% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.79%.
Axogen's revenue in 2026 is $225,208,000.On average, 12 Wall Street analysts forecast AXGN's revenue for 2026 to be $14,094,891,454, with the lowest AXGN revenue forecast at $13,513,637,416, and the highest AXGN revenue forecast at $14,664,209,026. On average, 11 Wall Street analysts forecast AXGN's revenue for 2027 to be $16,414,198,863, with the lowest AXGN revenue forecast at $15,466,547,190, and the highest AXGN revenue forecast at $17,339,534,533.
In 2028, AXGN is forecast to generate $19,247,293,323 in revenue, with the lowest revenue forecast at $17,948,294,343 and the highest revenue forecast at $20,293,031,616.